Pasithea Therapeutics Stock (NASDAQ:KTTA)
Previous Close
$0.75
52W Range
$0.65 - $7.50
50D Avg
$0.80
200D Avg
$1.92
Market Cap
$5.43M
Avg Vol (3M)
$4.67M
Beta
0.26
Div Yield
-
KTTA Company Profile
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.